|drug699||Capillary and salivary sampling Wiki||1.00|
|drug2413||Passed infection of SARS-CoV-2 Wiki||1.00|
|drug3323||Taking blood samples (capillary and venous), saliva sampling and nasopharyngeal sampling. Wiki||0.71|
|D006330||Heart Defects, Congenital NIH||0.71|
|D018352||Coronavirus Infections NIH||0.03|
There is one clinical trial.
The study will analyze the prevalence of cardiac involvement of health care workers from the University Hospital of Salamanca (HUSA) who have overcome SARS-CoV-2 infection. Participants will undergo a clinical evaluation, electrocardiogram (EKG), cardiac magnetic resonance (CMR) and blood analysis including NT-proBNP, troponin, cellular and humoral immunity and genetics.
Description: Prevalence of myocardial damage suggestive of myocarditis assessed by cardiac magnetic resonanceMeasure: Myocarditis Time: up to 3 months
Description: Prevalence of pericarditis assessed by clinical criteriaMeasure: Pericarditis Time: up to 3 months
Description: Prevalence of atrial fibrillation on EKGMeasure: Atrial fibrillation Time: up to 3 months
Description: Prevalence of ischemic heart disease assessed by cardiac magnetic resonanceMeasure: Ischemic heart disease Time: up to 3 months
Description: Prevalence of dilatation of right heart chambers assessed by cardiac magnetic resonanceMeasure: Dilatation of right heart chambers Time: up to 3 months
Description: Prevalence of valvular heart disease assessed by cardiac magnetic resonanceMeasure: Valvular hear disease Time: up to 3 months
Description: Prevalence of prolonged QT interval on EKGMeasure: Rhythm disorders Time: up to 3 months
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports